Medicines
- Augtyro repotrectinib · No generic yet Advanced solid tumors with an NTRK gene fusion
- Enhertu fam-trastuzumab deruxtecan-nxki · No generic yet HER2-positive solid tumors
- Jemperli dostarlimab · No generic yet Advanced solid tumors with dMMR (mismatch repair deficient)
- Keytruda Qlex pembrolizumab and berahyaluronidase alfa-pmph · No generic yet Solid tumors with MSI-H, dMMR or TMB-H test results
- Mekinist trametinib · No generic yet Other solid tumors with a BRAF mutation
- Retevmo selpercatinib · No generic yet Other solid tumors with a RET gene fusion
- Rozlytrek entrectinib · No generic yet Solid tumors with an NTRK gene fusion
- Tafinlar dabrafenib · No generic yet Solid tumors with a BRAF gene change
- Vitrakvi larotrectinib · No generic yet Solid tumors with an NTRK gene fusion
From each medicine’s FDA label. Only your prescriber can say which one is right for you, and many are prescribed for other reasons too.